HRT Financial’s Gain Therapeutics GANX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$25K Buy
+14,903
New +$27.2K ﹤0.01% 4506
2026
Q1
– Sell
-55,679
Closed -$179K – 4143
2025
Q4
$179K Buy
55,679
+35,962
+182% +$96K ﹤0.01% 2680
2025
Q3
$34K Buy
+19,717
New +$33.3K ﹤0.01% 2650

Other funds holding GANX

HRT Financial's GANX Position: Q3 2026 in Review

HRT Financial opened a new position in Gain Therapeutics (GANX) in Q3 2026: 14,903 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #4506 among its holdings. This is a return to the name: HRT Financial previously reported a position in GANX as recently as Q4 2025.

HRT Financial first reported a position in GANX in Q3 2025 and has held it in 3 quarters since. The position peaked at $179K in Q4 2025. 50 funds tracked by Wall St. Rank hold GANX as of Q3 2026.

  • HRT Financial held 14,903 shares of Gain Therapeutics worth $25K as of Q3 2026.
  • Gain Therapeutics was a new HRT Financial position in Q3 2026.
  • Gain Therapeutics made up ﹤0.01% of HRT Financial's portfolio in Q3 2026, its #4506 holding.
  • HRT Financial first reported a position in Gain Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • HRT Financial's Gain Therapeutics position peaked at $179K in Q4 2025.
  • 50 funds tracked by Wall St. Rank held Gain Therapeutics as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.